The Double Annotation

DNA methylation — adding methyl groups to cytosine bases — is one regulatory layer. RNA methylation — adding methyl groups to adenosine in mRNA (m6A) — is another. Both are epigenetic: they modify the chemical landscape without changing the underlying sequence. Both influence gene expression. Both have been studied for decades.

They were studied separately. DNA methylation researchers and RNA methylation researchers attended different conferences, published in different journals, and built different models. The implicit assumption: two independent regulatory systems operating on different molecules.

Fuks and Quarto found that they form a single complementary system. During embryonic stem cell differentiation, the Mettl3-Mettl14 complex (which writes m6A marks on RNA) and Dnmt1 (which maintains DNA methylation patterns) function as an axis. When both markers are present on a gene, activation is more effective than either alone. When one system malfunctions, gene activity diminishes — not just the activity that the malfunctioning system controls, but the activity that both systems jointly regulate.

The division of labor is architectural. DNA methylation organizes which genes are available — a structural layer that defines the accessible repertoire. RNA methylation dynamically adjusts how those available genes are used — a tuning layer that modulates expression levels in real time. Organization and adjustment. Blueprint and thermostat.

The therapeutic implication is direct: drugs targeting only DNA methylation or only RNA methylation are intervening on half a system. The interaction between the two layers is where regulation happens. The gene doesn’t have one annotation. It has two, and they read each other.